GlassScriptPhysician profile
Sheila S Newcomb
NPI 1285836692
$2,663.12
in general payments reported to CMS, 2019-2025
27 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $337 · 2021: $310 · 2022: $392 · 2023: $451 · 2024: $476 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.01 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $817.45 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $251.88 | 2021-2025 | |
| Exeltis, USA INC. | $219.63 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $209.62 | 2019-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Organon LLC | $184.84 | 2021-2025 | Jada System, Nexplanon |
| Roche Diagnostics Corporation | $159.13 | 2019-2021 | |
| Minerva Surgical, INC | $92.78 | 2024 | |
| Pfizer INC. | $90.65 | 2022-2023 | |
| Therapeuticsmd, INC. | $78.90 | 2019-2020 | |
| Astellas Pharma US INC | $72.07 | 2023-2024 | Veozah |
| Mission Pharmacal Company | $56.07 | 2019-2021 | |
| Agile Therapeutics, INC. | $55.08 | 2021-2023 | Twirla |
| Merck Sharp & Dohme LLC | $44.93 | 2020-2021 | |
| Allergan, INC. | $44.17 | 2019 | |
| Sage Therapeutics, LLC | $40.54 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $40.26 | 2025 | Myfembree |
| Evofem Biosciences, INC. | $35.47 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.86 | 2019 | |
| Myovant Sciences INC. | $26.88 | 2021-2022 | |
| Avion Pharmaceuticals | $19.02 | 2023 | Balcoltra |
| Exact Sciences Corporation | $16.20 | 2023 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $15.24 | 2024 | Exparel |
| Intuitive Surgical, INC. | $15.05 | 2019 | |
| Axonics, INC. | $14.48 | 2023 | Bulkamid |
| Meditrina | $12.85 | 2025 | |
| Zyla Life Sciences, INC. | $11.55 | 2019 | |
| Channel Medsystems, INC. | $6.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Newcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.